Adducin expression in cutaneous and oral lesions: alpha- and beta-adducin transcripts down-regulate with keratinocyte differentiation in stratified epithelia
- PMID:12950024
- DOI: 10.1002/path.1389
Adducin expression in cutaneous and oral lesions: alpha- and beta-adducin transcripts down-regulate with keratinocyte differentiation in stratified epithelia
Abstract
Adducin is a heterodimer of alpha- with beta- or gamma-subunits that regulates the assembly of the spectrin-based membrane skeleton in erythrocytes. Although adducin has been identified in various non-erythroid cells and tissues, it has been localized at intercellular junctions only in keratinocytes and epidermis. However, no data are available yet on the regulation of individual adducin genes in differentiating versus hyperproliferating keratinocytes. Due to the unavailability of mono-specific antibodies for individual adducins, this study has used RT-PCR and in situ hybridization to investigate the expression of alpha- and beta-adducins in cultured cells and in stratified epithelia including cutaneous and oral lesions. Using RT-PCR, the alpha-transcripts were consistently expressed in all cell lines tested, as well as in normal interfollicular epidermis, whereas the beta-transcripts were more variable and were strongly expressed in K562, A431, and primary keratinocytes. However, in normal skin, oral mucosa, and attached gingivae, the levels of alpha-transcripts closely paralleled those for the beta-subunit. In most normal tissues, adducin expression was observed primarily in the proliferating compartments including the basal layer and lower suprabasal layers. Expression of both genes was also up-regulated in skin diseases characterized by increased cell proliferation and keratinocyte activation, such as basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and psoriasis. It was observed that, in most cases, the expression of both alpha- and beta-adducin was accompanied by increased expression of the proliferation marker Ki-67 and keratins K6 and K16. Differentiating keratinocytes in normal epithelia as well as in tumours appear to suppress the expression of adducin transcripts. The data suggest that the expression of adducin genes may be linked to cell proliferation and starts to down-regulate at the onset of differentiation.
Copyright 2003 John Wiley & Sons, Ltd.
Similar articles
- Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes.Park GT, Seo EY, Lee KM, Lee DY, Yang JM.Park GT, et al.Br J Dermatol. 2006 Mar;154(3):411-8. doi: 10.1111/j.1365-2133.2005.07037.x.Br J Dermatol. 2006.PMID:16445768
- Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines.Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ.Hu L, et al.Cancer Res. 1991 Aug 1;51(15):3972-81.Cancer Res. 1991.PMID:1713123
- DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.Boldrup L, Coates PJ, Gu X, Nylander K.Boldrup L, et al.J Pathol. 2007 Dec;213(4):384-91. doi: 10.1002/path.2237.J Pathol. 2007.PMID:17935121
- Expression, regulation, and function of the SPR family of proteins. A review.Tesfaigzi J, Carlson DM.Tesfaigzi J, et al.Cell Biochem Biophys. 1999;30(2):243-65. doi: 10.1007/BF02738069.Cell Biochem Biophys. 1999.PMID:10356644Review.
- Calcium--a central regulator of keratinocyte differentiation in health and disease.Elsholz F, Harteneck C, Muller W, Friedland K.Elsholz F, et al.Eur J Dermatol. 2014 Nov-Dec;24(6):650-61. doi: 10.1684/ejd.2014.2452.Eur J Dermatol. 2014.PMID:25514792Review.
Cited by
- Increased expression of phosphorylated adducin in tumor cells.Luo C, Wang G, Ying H, Shen J, Gilligan DM.Luo C, et al.J Int Med Res. 2020 Apr;48(4):300060520910646. doi: 10.1177/0300060520910646.J Int Med Res. 2020.PMID:32237935Free PMC article.
- Adducin in tumorigenesis and metastasis.Luo C, Shen J.Luo C, et al.Oncotarget. 2017 Jul 18;8(29):48453-48459. doi: 10.18632/oncotarget.17173.Oncotarget. 2017.PMID:28476036Free PMC article.Review.
- Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel.Ahmed M, Semreen AM, Giddey AD, Ramadan WS, El-Awady R, Soares NC, El-Huneidi W, Bustanji Y, Alqudah MAY, Alzoubi KH, Semreen MH.Ahmed M, et al.Ann Med. 2023;55(2):2305308. doi: 10.1080/07853890.2024.2305308. Epub 2024 Jan 22.Ann Med. 2023.PMID:38253025Free PMC article.
- A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.Shen N, Liu C, Li J, Chen X, Yang Y, Zhu Y, Gong Y, Gong J, Zhong R, Cheng L, Miao X.Shen N, et al.PLoS One. 2015 Mar 27;10(3):e0121485. doi: 10.1371/journal.pone.0121485. eCollection 2015.PLoS One. 2015.PMID:25816007Free PMC article.
- Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion.Ma PC, Tretiakova MS, Nallasura V, Jagadeeswaran R, Husain AN, Salgia R.Ma PC, et al.Br J Cancer. 2007 Aug 6;97(3):368-77. doi: 10.1038/sj.bjc.6603884. Epub 2007 Jul 31.Br J Cancer. 2007.PMID:17667909Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Research Materials